Dr. Commins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Dept of Medicine
Washington, DC 20007Phone+1 202-444-8168Fax+1 877-303-1460
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2016 - 2019
- Georgetown University School of MedicineClass of 2016
Certifications & Licensure
- DC State Medical License 2016 - 2024
- PA State Medical License 2021 - 2022
- VA State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 44 citationsInhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing’s sarcomaStefan K. Zöllner, Saravana P. Selvanathan, Garrett T. Graham, Ryan M. T. Commins, Sung Hyeok Hong
Science Signaling. 2017-10-03 - 10 citationsSynthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma.Perrer N. Tosso, Yali Kong, Lauren M. Scher, Ryan Cummins, Jeffrey Schneider
Journal of Medicinal Chemistry. 2014-12-12
Journal Articles
- Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcomaZollner SK, Selvanathan SP, Graham GT, Commins RMT, Hong SH, Moseley E, Parks S, Haladyna JN, Erkizan HV, Dirksen U, Hogarty MD, Uren A, Toretsky JA, Science Signalling, 10/3/2017
Books/Book Chapters
Abstracts/Posters
- EWS-FLI1 targeted small molecule YK-4-279 synergizes with vinca alkaloids through double hit to mitotic machineryZoller SK, Commins RMT, Selvanathan SP, Graham GT, Hong SH, Erkizan HV, Uren A, Toretsky JA, AACR Annual Meeting 2015, Philadelphia, PA, 2015
- Combinations of Current Chemotherapies with YK-4-279 in Ewing Sarcoma.Commins RMT, Hong SH, Barber-Rotenberg J, Uren A, Toretsky J, 16th Annual Meeting of the Connective Tissue Oncology Society, Chicago, IL, 10/1/2011
Committees
- Student Representative, Medical School Admissions Committee 2015 - 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: